CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with

Ning Zhang1, Qunchao Ma1, Yayu You1

  • 1Department of Cardiology, Cardiovascular Key Laboratory of Zhejiang Province, Second Affiliated Hospital, Zhejiang University College of Medicine, 88 Jiefang Rd, Hangzhou, Zhejiang Province, 310009, PR China.

Insights

Targeting C-X-C chemokine receptor 4 (CXCR4) on macrophages may treat hypertension-induced heart failure with preserved ejection fraction (HFpEF). Blocking CXCR4 reduces cardiac inflammation and fibrosis, improving diastolic function in HFpEF models.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Hypertension causes cardiac remodeling, leading to heart failure with preserved ejection fraction (HFpEF).
  • Monocyte/macrophage infiltration and inflammation are key in hypertension-induced cardiac remodeling.
  • The role of C-X-C chemokine receptor 4 (CXCR4) in macrophage function during HFpEF progression is not fully understood.

Purpose of the Study:

  • To investigate the role of macrophagic CXCR4 in the pathogenesis of HFpEF.
  • To determine if targeting CXCR4 could be a therapeutic strategy for hypertension-induced HFpEF.

Main Methods:

  • Utilized a pressure overload mouse model to induce HFpEF in wild-type and myeloid-specific CXCR4-deficient mice.
  • Analyzed cardiac function, macrophage infiltration, and inflammatory markers.
  • Investigated macrophage-to-fibroblast signaling and gene expression profiles.

Main Results:

  • Increased circulatory CXCR4+ monocytes were observed in HFpEF patients with hypertension.
  • Myeloid-specific CXCR4 deficiency in mice reduced cardiac macrophage infiltration, inflammation, fibrosis, and improved diastolic function.
  • CXCR4 promoted pro-inflammatory cytokine production and myofibroblast differentiation via CXCL3, partly by suppressing PPARγ activity.

Conclusions:

  • Macrophagic CXCR4 exacerbates hypertension-induced diastolic dysfunction in HFpEF.
  • CXCR4+ macrophage infiltration drives cardiac inflammation and fibrosis.
  • CXCR4 represents a potential therapeutic target for hypertension-induced HFpEF.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
90
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
77
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
73
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
106
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K